{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:16:09Z","timestamp":1783163769666,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["C-0030-2018"],"award-info":[{"award-number":["C-0030-2018"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["C-0028-2018"],"award-info":[{"award-number":["C-0028-2018"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["SAS 111226"],"award-info":[{"award-number":["SAS 111226"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CPI13\/00003"],"award-info":[{"award-number":["CPI13\/00003"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CPII18\/00030"],"award-info":[{"award-number":["CPII18\/00030"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF 2010-17213"],"award-info":[{"award-number":["SAF 2010-17213"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.eimce.2020.11.026","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T03:25:58Z","timestamp":1654485958000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergic effect of metabolic syndrome and lipodystrophy on oxidative stress and inflammation process in treated HIV-patients"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8248-3904","authenticated-orcid":false,"given":"Carmen Mar\u00eda","family":"Gonz\u00e1lez-Domenech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac J.","family":"Plaza-Andrades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-9606","authenticated-orcid":false,"given":"Lourdes","family":"Garrido-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Queipo-Ortu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2020.11.026_bib0210","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","article-title":"Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study","volume":"384","author":"Murray","year":"2014","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.eimce.2020.11.026_bib0215","unstructured":"World Health Organization. HIV\/AIDS, Key facts; 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids [accessed 3.12.19]."},{"key":"10.1016\/j.eimce.2020.11.026_bib0220","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2020.11.026_bib0225","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1097\/QAD.0000000000001587","article-title":"Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients","volume":"31","author":"Lemoine","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.eimce.2020.11.026_bib0230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0b013e32834ef599","article-title":"From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management","volume":"25","author":"Lemoine","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.eimce.2020.11.026_bib0235","doi-asserted-by":"crossref","first-page":"e0150970","DOI":"10.1371\/journal.pone.0150970","article-title":"A meta-analysis of the metabolic syndrome prevalence in the global HIV-infected population","volume":"11","author":"Nguyen","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.eimce.2020.11.026_bib0240","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death. A systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eimce.2020.11.026_bib0245","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QAI.0b013e318074ef83","article-title":"HIV and metabolic syndrome","volume":"45","author":"Bonfanti","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimce.2020.11.026_bib0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1086\/518619","article-title":"Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV cohort study","volume":"45","author":"Ledergerber","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2020.11.026_bib0255","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1258\/095646207780132415","article-title":"Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy","volume":"18","author":"Palacios","year":"2007","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.eimce.2020.11.026_bib0260","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc07-2013","article-title":"Incidence and risk factors for new-onset diabetes in HIV-infected patients","volume":"31","author":"De Wit","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eimce.2020.11.026_bib0265","doi-asserted-by":"crossref","unstructured":"Husain NE, Ahmed MH. Managing dyslipidemia in HIV\/AIDS patients: Challenges and solutions. HIV AIDS (Auckl) 2014; 7:1\u201310. eCollection 2015.","DOI":"10.2147\/HIV.S46028"},{"key":"10.1016\/j.eimce.2020.11.026_bib0270","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5603\/KP.a2017.0249","article-title":"Metabolic syndrome in HIV infected adults in Poland","volume":"76","author":"Rogalska-P\u0142o\u0144ska","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.eimce.2020.11.026_bib0275","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAI.0b013e3182690e3c","article-title":"Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals","volume":"61","author":"Krishnan","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimce.2020.11.026_bib0280","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0956462417732226","article-title":"Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and\/or metabolic syndrome in HIV-infected patients: a systematic review and meta-analysis","volume":"29","author":"Echecopar-Sabogal","year":"2018","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.eimce.2020.11.026_bib0285","first-page":"51","article-title":"S\u00edndrome metab\u00f3lico en pacientes con lipodistrofia infectados por el VIH","volume":"18","author":"Jeric\u00f3","year":"2006","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.eimce.2020.11.026_bib0290","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2334-11-246","article-title":"Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients","volume":"11","author":"Freitas","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimce.2020.11.026_bib0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00002018-200023010-00004","article-title":"Lipodystrophy syndrome in HIV infection what is it, what causes it and how can it be managed?","volume":"23","author":"Behrens","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.eimce.2020.11.026_bib0300","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1055329004271187","article-title":"Lipodystrophy syndrome: the morphologic and metabolic effects of antiretroviral therapy in HIV infection","volume":"15","author":"Norris","year":"2004","journal-title":"J Assoc Nurses AIDS Care"},{"key":"10.1016\/j.eimce.2020.11.026_bib0305","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.revmed.2012.11.008","article-title":"Lipodystrophies","volume":"34","author":"Fardet","year":"2013","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.eimce.2020.11.026_bib0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jinf.2010.06.002","article-title":"The HIV-1\/HAART associated metabolic syndrome \u2013 novel adipokines, molecular associations and therapeutic implications","volume":"61","author":"Tsiodras","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.eimce.2020.11.026_bib0315","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/INF.0000000000001394","article-title":"Adiponectin, leptin and inflammatory markers in HIV-associated metabolic syndrome in children and adolescents","volume":"36","author":"Espiau","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.eimce.2020.11.026_bib0320","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/1471-2334-14-347","article-title":"Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome","volume":"14","author":"Freitas","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimce.2020.11.026_bib0325","unstructured":"International Diabetes Federation (IDF). The IDF consensus worldwide definition of the Metabolic Syndrome; 2006. https:\/\/www.idf.org\/e-library\/consensus-statements\/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome [accessed 3.12.19]."},{"key":"10.1016\/j.eimce.2020.11.026_bib0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacl.2010.02.005","article-title":"\u201cAtherogenic index of plasma\u201d (log10 triglyceride\/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events","volume":"4","author":"Onat","year":"2010","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.eimce.2020.11.026_bib0335","series-title":"UpToDate textbook of medicine","article-title":"Estimation of cardiovascular risk in an individual patient without known cardiovascular disease","author":"Wilson","year":"2010"},{"key":"10.1016\/j.eimce.2020.11.026_bib0340","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.metabol.2006.02.024","article-title":"Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy","volume":"55","author":"Estrada","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.eimce.2020.11.026_bib0345","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbalip.2011.10.002","article-title":"Serum triglycerides and risk of cardiovascular disease","volume":"1821","author":"Boullart","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.eimce.2020.11.026_bib0350","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11904-016-0330-z","article-title":"Metabolic complications and glucose metabolism in HIV infection: a review of the evidence","volume":"13","author":"Willig","year":"2016","journal-title":"Current HIV\/AIDS Rep"},{"key":"10.1016\/j.eimce.2020.11.026_bib0355","first-page":"1659","article-title":"Inflammation-modulating cytokine profile and lipid interaction in HIV-related risk factors for cardiovascular diseases","volume":"12","author":"Gori","year":"2016","journal-title":"Clin Risk Manag"},{"key":"10.1016\/j.eimce.2020.11.026_bib0360","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3389\/fimmu.2018.01469","article-title":"Immune activation, proinflammatory cytokines, and conventional risks for cardiovascular disease in HIV patients: a case\u2013control study in Bahia, Brazil","volume":"9","author":"Brites-Alves","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.eimce.2020.11.026_bib0365","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ki.2008.516","article-title":"Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease","volume":"111","author":"Cachofeiro","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.eimce.2020.11.026_bib0370","doi-asserted-by":"crossref","first-page":"5698931","DOI":"10.1155\/2016\/5698931","article-title":"Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?","volume":"2016","author":"Biswas","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.eimce.2020.11.026_bib0375","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JAD-190764","article-title":"Vascular risk factors and Alzheimer's disease: blood-brain barrier disruption, metabolic syndromes, and molecular links","volume":"73","author":"He","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.eimce.2020.11.026_bib0380","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Lv","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"10.1016\/j.eimce.2020.11.026_bib0385","first-page":"9","article-title":"Mechanism of Darunavir (DRV)\u2018s high genetic barrier to HIV-1 resistance: a key V32I substitution in protease rarely occurs, but once it occurs, it predisposes HIV-1 To develop DRV resistance","author":"Aoki","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.eimce.2020.11.026_bib0390","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14740338.2019.1644317","article-title":"Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment","volume":"18","author":"Lagathu","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.eimce.2020.11.026_bib0395","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1468-1293.2012.01026.x","article-title":"Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy","volume":"13","author":"Hileman","year":"2012","journal-title":"HIV Med"},{"key":"10.1016\/j.eimce.2020.11.026_bib0400","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3851\/IMP3319","article-title":"Efficacy and safety of dolutegravir plus boosted-darunavir dual therapy among highly treatment-experienced patients","volume":"24","author":"Vizcarra","year":"2019","journal-title":"Antivir Ther"},{"key":"10.1016\/j.eimce.2020.11.026_bib0405","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/hiv.12530","article-title":"Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia","volume":"18","author":"Echeverr\u00eda","year":"2017","journal-title":"HIV Med"},{"key":"10.1016\/j.eimce.2020.11.026_bib0410","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3851\/IMP3160","article-title":"Impact of CCR5, integrase and protease inhibitors on human endothelial cell function, stress, inflammation and senescence","volume":"22","author":"Afonso","year":"2017","journal-title":"Antivir Ther"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X22001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:27:31Z","timestamp":1783160851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X22001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2529993X22001149"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2020.11.026","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergic effect of metabolic syndrome and lipodystrophy on oxidative stress and inflammation process in treated HIV-patients","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2020.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}